Choosing your fifth character requires a little more detective work under the new code set.
Whether anaplastic large cell lymphoma is ALK-positive or ALK-negative can change a patient’s prognosis. Under ICD-10-CM, you’ll be able to use your coding to reflect this important information.
ICD-9-CM Code:
ICD-10-CM Codes:
The diagnosis: Anaplastic large cell lymphoma (ALCL) is a T-cell non-Hodgkin’s lymphoma. The ALK referenced in the ICD-10-CM codes is anaplastic lymphoma kinase protein. ALK-negative ALCLs are prone to being more aggressive than ALK-positive ALCLs. Relapse is also more likely with ALK-negative ALCLs.
ICD-9-CM coding rules: A single ICD-9-CM code, 200.61, applies to both ALK-positive and ALK-negative ALCL.
ICD-10-CM changes: ICD-10-CM requires you to identify whether the ALCL is ALK-positive or ALK-negative.
Documentation: For you to choose the appropriate code, the medical record needs to specify ALK-positive or ALK-negative. You also will need to know the specific lymph node sites affected, as explained in more detail below.
Coder tips: The featured ICD-9-CM and ICD-10-CM codes are specific to ALCL of lymph nodes of the inguinal region (groin and lower abdomen) and lower limb. It is the fifth character that identifies the site.
Under ICD-9-CM, you have a total of eight fifth-digit options for 200.6x based on the location of the affected lymph nodes:
ICD-10-CM’s fifth-character options are similar, but you have an additional choice. Unlike ICD-9-CM, ICD-10-CM separates unspecified site from extranodal and solid organ sites. For both C84.6- and C84.7-, the fifth characters identify the following anatomic areas:
Remember: CMS has finalized the ICD-10-CM compliance date of Oct. 1, 2014. When ICD-10-CM goes into effect, you should apply the code set and official guidelines in effect for the date of service reported. Learn more at www.cms.gov/ICD10/ and www.cdc.gov/nchs/icd/icd10cm.htm#10update.